Aspen Aerogels (NYSE:ASPN) Major Shareholder Wood River Capital, Llc Sells 12,280,426 Shares of Stock

Key Points

• Major shareholder Wood River Capital sold 12.28 million Aspen Aerogels shares at an average price of $4.73, generating approximately $58.1 million. The transaction was disclosed in an SEC filing.
• Aspen Aerogels shares fell $0.39 to $5.29 during Thursday trading, while the company reported a quarterly loss of $0.22 per share and revenue of $49.85 million, exceeding analyst expectations.
• Analyst sentiment remains mixed, with four Buy, one Hold and two Sell ratings; the stock carries an overall “Hold” consensus and a $5.94 average price target.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) major shareholder Wood River Capital, Llc sold 12,280,426 shares of the business's stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Aspen Aerogels Price Performance

Aspen Aerogels stock traded down $0.39 during midday trading on Thursday, reaching $5.29. The company had a trading volume of 2,364,746 shares, compared to its average volume of 683,511. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. Aspen Aerogels, Inc. has a 12-month low of $2.30 and a 12-month high of $9.35. The company has a market capitalization of $439.18 million, a P/E ratio of -3.46 and a beta of 2.97. The firm's fifty day simple moving average is $5.19 and its 200-day simple moving average is $4.87.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $49.85 million during the quarter, compared to analysts' expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. As a group, equities analysts anticipate that Aspen Aerogels, Inc. will post -0.69 EPS for the current year.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently made changes to their positions in the company. Concurrent Investment Advisors LLC boosted its holdings in Aspen Aerogels by 6.7% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company's stock valued at $203,000 after acquiring an additional 2,000 shares during the period. Royal Bank of Canada increased its stake in Aspen Aerogels by 95.8% during the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company's stock worth $29,000 after purchasing an additional 4,169 shares during the period. Legal & General Group Plc purchased a new stake in Aspen Aerogels during the second quarter worth about $44,000. Clarus Group Inc. acquired a new stake in shares of Aspen Aerogels during the first quarter worth about $36,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Aspen Aerogels during the fourth quarter worth about $30,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

ASPN has been the subject of a number of research reports. Wall Street Zen lowered shares of Aspen Aerogels from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Barclays raised their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 11th. B. Riley Financial reaffirmed a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital reiterated a "buy" rating and issued a $7.75 price objective on shares of Aspen Aerogels in a report on Friday, August 7th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Aspen Aerogels in a report on Monday. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat.com, Aspen Aerogels has an average rating of "Hold" and a consensus target price of $5.94.

About Aspen Aerogels

Aspen Aerogels, Inc is a technology company that develops, manufactures and sells advanced aerogel-based materials. Aerogels are highly porous materials designed to provide thermal insulation, fire protection and other performance benefits in applications where conventional insulation may be less effective or require more space.

The company serves the energy, industrial and automotive markets. Its products include thermal barriers for electric vehicle batteries, insulation materials for industrial and energy infrastructure, and specialty aerogel products used in applications involving heat management, fire mitigation and cryogenic or high-temperature environments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.